• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Transfected Stable Cell Lines

Human HRAS (G13D) BAF3 Cell Line

  • For research use only

Cat No.

ABC-X0019C

Product Type

Overexpression Stable Cell Lines

Cell Type

Lymphocyte

Species

Human

Host Cell

BAF3

Source Organ

Lymphatic

Disease

Normal

Storage

Liquid Nitrogen

The HRAS (G13D) BAF3 cell line provides a powerful tool for studying tumorigenesis mechanisms, supporting drug development and validation of RAS treatment.

Product Image

Description

Human HRAS (G13D) BAF3 Cell Line is a genetically engineered model derived from selected murine Ba/F3 parental cell line based on customers’ requirement. HRAS (G13D) BAF3 mutant cell line is generated by stable integration of exogenous human HRAS gene harboring the G13D point mutation into Ba/F3 host cells using our optimized transduction of lentiviral vectors.
Target
HRAS encodes a member of the RAS GTPase family that regulates cell proliferation and differentiation through the MAPK and PI3K signaling pathways. The G13D mutation results in constitutive activation of HRAS and is implicated in tumorigenesis across several solid cancers, including bladder and thyroid carcinomas. AcceGen offers generation of stable overexpression and RAS-mutant cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.

Species

Human

Cat.No

ABC-X0019C

Product Category

Transfected Stable Cell Lines

Size/Quantity

1 vial

Cell Type

Lymphocyte

Growth Mode

Suspension

Shipping Info

Dry Ice

Growth Conditions

37 °C, 5% CO₂

Source Organ

Lymphatic

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Overexpression Stable Cell Lines

Host Cell

BAF3

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • The HRAS (G13D) BAF3 Cell Line serves as a powerful tool to investigate RAS mutation-driven oncogenesis and therapeutic sensitivity. This model enables mechanistic studies of downstream MAPK/ERK activation, IL-3-independent transformation, and resistance to RAS pathway inhibitors. It is utilized for drug discovery and validation of anti-RAS therapeutic strategies.

Inquiring Human HRAS (G13D) BAF3 Cell Line

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button